{"url_path":"/sec/novt/8-k/2026-06-09/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-09","source_url":"https://www.sec.gov/Archives/edgar/data/1076930/0001193125-26-262867-index.html","accession_number":"0001193125-26-262867","cik":"0001076930","ticker":"NOVT","issuer_name":"NOVANTA INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1076930/0001193125-26-262867-index.html","primary_entity_key":"0001076930","primary_entity_name":"NOVANTA INC"},"word_count":173,"has_tables":true,"body_markdown":"Item 9.01 Financial Statements and Exhibits.\n\n(d) Exhibits.\n\n \n\nExhibit\n\nNumber\n\nDescription\n\n 2.1*\n\n \n\n[Equity Purchase Agreement, dated as of June 8, 2026, by and among Novanta Medical Technologies Corp., Novanta Corporation, Novanta Inc., Runway Midco, LLC and Runway Buyer, LLC](novt-ex2_1.htm)\n\n 10.1\n\n \n\n[Third Amendment to Fourth Amended and Restated Credit Agreement, dated as of June 8, 2026](novt-ex10_1.htm)\n\n 99.1\n\n \n\n[Press Release issued June 9, 2026 by the Company](novt-ex99_1.htm)\n\n 99.2\n\n \n\n[Investor Conference Call Presentation issued June 9, 2026](novt-ex99_2.htm)\n\n 104\n\nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n* All schedules and exhibits to the Purchase Agreement have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company agrees to furnish a copy of such schedules and exhibits, or any section thereof, to the SEC upon request.\n\n \n\n \n\nSIGNATURES\n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.\n\n \n\nNovanta Inc.\n\nDate: June 9, 2026\n\nBy:\n\n/s/ Robert J. Buckley\n\nRobert J. Buckley\n\nChief Financial Officer"}